Researchers conducted a study that compared vaginal cytokine and microbiota profiles before and after condomless vaginal intercourse between women who use vaginal lubricants vs those who do not.
Investigators conducted a study to determine the effects of antiretroviral therapy on weight gain in patients with HIV infection.
Researchers conducted a study to assess virologic outcomes and adherence associated with treatment with bictegravir/emtricitabine/tenofovir alafenamide in African American patients with HIV infection.
Researchers conducted a study that compared virologic suppression, lipid control, and safety profiles of patients with HIV infection who switch from ritonavir-boosted darunavir to doravirine (DOR) therapy vs those who continued DOR therapy.
Researchers sought to determine whether patients with B-NHL who had treatment with anti-CD20 antibodies had an impaired serological response to an mRNA COVID-19 vaccine.
Researchers conducted a modeling study to determine the projected long-term impact of the COVID-19 pandemic on outcomes associated with hepatitis C virus care.
Cutaneous reactions to mRNA-based COVID-19 vaccines are characterized.
Researchers assessed efficacy and safety outcomes of patients with moderate to severe COVID-19 who received standard care alone; with sofosbuvir plus daclatasvir; or with sofosbuvir plus ravidasvir.
A review of clinical findings and treatments for the nail manifestations of COVID-19 is offered.
Brexafemme is a triterpenoid antifungal.
